-
Signature
-
Leslie W. Kreis, Jr By: /s/ Daniel Schwarz, as attorney-in-fact
-
Stock symbol
-
LTRN
-
Transactions as of
-
Jan 17, 2024
-
Transactions value $
-
$2
-
Form type
-
4
-
Date filed
-
1/19/2024, 04:30 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LTRN |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
$23K |
+7.35K |
+10.24% |
$3.13 |
79.1K |
Jan 17, 2024 |
By Bios Fund II NT, LP |
F2, F3, F4 |
transaction |
LTRN |
Common Stock |
Sale |
-$23K |
-5.48K |
-6.92% |
$4.20 |
73.6K |
Jan 17, 2024 |
By Bios Fund II NT, LP |
F1, F2, F3, F4 |
transaction |
LTRN |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
$172K |
+54.9K |
+10.23% |
$3.13 |
591K |
Jan 17, 2024 |
By Bios Fund II QP, LP |
F2, F3, F4 |
transaction |
LTRN |
Common Stock |
Sale |
-$172K |
-40.9K |
-6.92% |
$4.20 |
550K |
Jan 17, 2024 |
By Bios Fund II QP, LP |
F1, F2, F3, F4 |
transaction |
LTRN |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
$52.6K |
+16.8K |
+10.24% |
$3.13 |
181K |
Jan 17, 2024 |
By Bios Fund II, LP |
F2, F3, F4 |
transaction |
LTRN |
Common Stock |
Sale |
-$52.6K |
-12.5K |
-6.92% |
$4.20 |
168K |
Jan 17, 2024 |
By Bios Fund II, LP |
F1, F2, F3, F4 |
holding |
LTRN |
Common Stock |
|
|
|
|
|
218K |
Jan 17, 2024 |
By Bios Fund I QP, LP( |
F2, F3, F4 |
holding |
LTRN |
Common Stock |
|
|
|
|
|
372K |
Jan 17, 2024 |
By Bios Fund I, LP |
F2, F3, F4 |
holding |
LTRN |
Common Stock |
|
|
|
|
|
26.1K |
Jan 17, 2024 |
By BP Directors, LP |
F2, F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LTRN |
Series A Warrants |
Exercise of in-the-money or at-the-money derivative security |
$0 |
-7.35K |
-100% |
$0.00* |
0 |
Jan 17, 2024 |
Common Stock |
7.35K |
$3.13 |
By Bios Fund II NT, LP |
F2, F3, F4 |
transaction |
LTRN |
Series A Warrants |
Exercise of in-the-money or at-the-money derivative security |
$0 |
-54.9K |
-100% |
$0.00* |
0 |
Jan 17, 2024 |
Common Stock |
54.9K |
$3.13 |
By Bios Fund II QP, LP |
F2, F3, F4 |
transaction |
LTRN |
Series A Warrants |
Exercise of in-the-money or at-the-money derivative security |
$0 |
-16.8K |
-100% |
$0.00* |
0 |
Jan 17, 2024 |
Common Stock |
16.8K |
$3.13 |
By Bios Fund II, LP |
F2, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This Form 4 is the first of two Forms 4 filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 reporting persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 reporting person. The second Form 4 will be filed by Aaron Glenn Louis Fletcher as the designated filer.